Justin M. L. Stern

Associate

  • Justin M. L. Stern
  • Phone: +1 561 962 2107
    Fax: +1 305 675 3868

    Read Justin M. L. Stern's blog Import to Address Book

  • Duane Morris LLP
    1875 NW Corporate Boulevard
    Suite 300
    Boca Raton, FL 33431-8561
    USA

Justin M. L. Stern is a member of the firm's Trial Practice Group as well as the Cannabis industry group and focuses primarily on commercial litigation and regulatory compliance.

Mr. Stern is a 2018 summa cum laude graduate of the University of Miami School of Law, where he was online editor of the University of Miami Law Review and elected to the Order of the Coif, and a magna cum laude graduate of Columbia University, where he was elected to Phi Beta Kappa. 

Representative Matters

    Commercial and Real Estate Litigation

  • Currently represent the developer of mixed-use condominium complexes in related actions against the general contractor, alleging construction defect and various tort claims.
  • Obtained a preliminary injunction on behalf of publicly traded transportation and logistics conglomerate in civil litigation involving trade secret misappropriation claims.
  • Obtained full dismissal of breach of contract and civil trespass claims brought against a publicly traded telecommunications service provider arising from the alleged misplacement of certain underground fiber optic cables. Live Work Play Developers, LLC v. AT&T Corp. (Fla. Cir. Ct. 2019).
  • Regulatory/Administrative

  • Represented The Benchmark Company LLC, acting as underwriter in a $12.5 million offering of preferred stock for Fortress Biotech, Inc. (NASDAQ: FBIOP), a developer of pharmaceutical and biotechnology products and product candidates.
  • Represented B. Riley FBR, Inc., acting as sales agent in a $150 million at the market equity offering of common stock for Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company focused on the discovery, development and commercialization of vaccines to prevent serious infectious diseases, including a potential COVID-related vaccine.
  • Represented JMP Securities LLC and Oppenheimer & Co., acting as underwriters in a $25 million public offering of common stock and related warrants for Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company primarily focused on developing and commercializing innovative products for acute care settings.
  • Represented JMP Securities LLC, acting as sales agent in a $25 million at the market equity offering of common stock for iCAD, Inc. (NASDAQ: ICAD), a global medical technology company that provides innovative cancer detection and therapy solutions.
  • Represent pharmacy operator in connection with civil administrative enforcement action brought by the DEA.
  • Cannabis

  • Cannabis regulatory counsel to a venture capital firm focused on acquiring and developing businesses specializing in cannabis-related consumer goods.
  • Regulatory counsel to an aromatherapy and essential oils products manufacturer in connection with the company’s entry into the hemp-derived CBD market.
  • Cannabis regulatory counsel to multi-state medical marijuana operator.
  • Provided state-specific regulatory advice on the cultivation, manufacture, and sale of CBD products to publicly traded international cannabinoid company.
  • Advised a private credit asset management firm on cannabis-related regulatory matters in connection with its provision of a revolving credit facility to support the capital needs of a publicly traded supplier to businesses in the cannabis industry.

Admissions

  • Florida
  • U.S. District Court for the Southern District of Florida
  • U.S. District Court for the Middle District of Florida

Education

  • University of Miami School of Law, J.D., summa cum laude, 2018
    - Order of the Coif
    - Online Editor, University of Miami Law Review
  • Columbia University, B.A., magna cum laude, 2014
    - Phi Beta Kappa

Experience

  • Duane Morris LLP
    - Associate, 2018-present

Professional Activities

  • Federal Bar Association, 2019-present

  • Food and Drug Law Institute (FDLI), 2019-present
    - 2020 Austern Writing Awards Committee

Selected Publications

Duane Morris Alerts

Selected Speaking Engagements

  • Presenter, "Virtual Happy Hour with Update Magazine Authors Rick Ball and Justin Stern," Food and Drug Law Institute, April 30, 2020
  • Presenter, "Cannabis 303: Civil Litigation and COVID-19 Implications for the Cannabis Industry: An Unavoidable Consequence of a Maturing U.S. Cannabis Market," Duane Morris Cannabis Webinar Series, April 21, 2020
  • Speaker, "Risks Associated With Cannabis Banking," South Florida Compliance Association, February 11, 2020
  • Speaker, "Cannabis Issues in Commercial Real Estate," 6th Annual NAI Florida & Caribbean Conference, Intercontinental Miami, Miami, Florida, November 14-15, 2019
  • Speaker, "Overview of New Federal Rules on Hemp Production and Q&A," Duane Morris and American Trade Association for Cannabis and Hemp, Webinar, November 6, 2019
  • Presenter, "Cannabis 204: The Roundup of State Cannabis Legislation," Duane Morris Cannabis Webinar Series, August 20, 2019

  • Presenter, "Possession, Custody, or Control Under Fed. R. Civ. P. 34: Implications of Interpretation," Miami, FL, April 12, 2019